Novo Nordisk and Neose announce completion of initial phase 1 clinical trial of NN7128
- Details
- Category: Novo Nordisk

Phase III Study of Abbott's Investigational TriLipix(TM) in Combination With AstraZeneca's CRESTOR
- Details
- Category: Abbott

Bristol-Myers Squibb Pharma EEIG withdraws its marketing authorisation application for DuoCover
- Details
- Category: Bristol-Myers Squibb

Sanofi Pharma Bristol-Myers Squibb SNC withdraws its marketing authorisation for DuoPlavin
- Details
- Category: Sanofi

Amgen Posts Medical Education and Foundation Grants and Donations
- Details
- Category: Amgen

High Dose Lipitor Can Reduce the Risk of Cardiovascular Events in Bypass Surgery Patients
- Details
- Category: Pfizer

A promising start into 2008 for Nycomed
- Details
- Category: Nycomed

More Pharma News ...
- FivePrime and Pfizer Enter Oncology and Diabetes Collaboration
- First pre-pandemic vaccine approved to help protect against pandemic influenza
- Nexavar Significantly Extends Overall Survival in Liver Cancer by 47 percent
- Pfiser's List of Grants and Charitable Contributions
- Lapatinib (Tykerb/Tyverb) to be investigated in landmark early breast cancer trial
- Boehringer Ingelheim announces commitment to progressing science with the Bouquet Studies
- Actemra inhibits joint damage and improves physical function of patients with Rheumatoid Arthritis